Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: juvenile idiopathic arthritis

FDA Approves the Biosimilar Hadlima (Adalimumab-bwwd)

Michele B. Kaufman, PharmD, BCGP  |  September 16, 2019

Hadlima (adalimumab-bwwd), which is biosimilar to adalimumab, is now FDA approved to treat multiple autoimmune diseases…

Filed under:Biologics/DMARDsDrug Updates Tagged with:adalimumab-bwwdFDAFDA approvalHadlimaU.S. Food and Drug Administration (FDA)

ACR on Air: New Rheumatology Podcast Introduced

Susan Bernstein  |  September 2, 2019

A new podcast from the ACR provides in-depth discussions about newly published science, regulatory updates, advocacy and volunteer opportunities for the rheumatology community…

Filed under:Education & Training

phichet chaiyabin / shutterstock.com

Measles Is Back. How Does This Affect Patients with Rheumatic Disease?

Ruth Jessen Hickman, MD  |  August 16, 2019

Despite the presence of a highly effective vaccine, measles (rubeola) is still an important problem worldwide, one that has reemerged in some areas of the world where it had previously been almost eradicated. Rheumatology patients may have questions about whether they are sufficiently protected. Here we discuss key considerations for rheumatologists in light of recent…

Filed under:Conditions Tagged with:immunosuppressive drugsvaccineswashout

An Interdisciplinary & Holistic Approach to Alleviating Pediatric Pain

Carina Stanton  |  July 22, 2019

Interdisciplinary collaboration is proving valuable to address bio-psycho-social pain management in pediatric patients at Children’s Hospital Los Angeles…

Filed under:Conditions

Advanced Practice Providers Should Learn Musculoskeletal Ultrasound

Heather Benham, DNP, RN, CPNP, RhMSUS, on behalf of the ARP Practice Committee   |  June 17, 2019

I have worked as an advanced practice provider (APP) in pediatric rheumatology for nearly 16 years. My collaborating physicians have allowed me to function to the full extent of my scope of practice while allowing me to develop professionally within the subspecialty. My latest endeavor has been learning how to perform musculoskeletal ultrasound (MSUS) and…

Filed under:ConditionsPractice Support Tagged with:Advanced Practice CliniciansMusculoskeletal UltrasoundUltrasound

Shared Decision Making, Good Disease Control Are Key Components of JIA Management

Kelly Tyrrell  |  May 15, 2019

A group led by Sarah Ringold, MD, MS, assistant professor of rheumatology at Seattle Children’s Hospital, has developed a new guideline intended to provide recommendations for the treatment and monitoring of children with juvenile idiopathic arthritis (JIA) manifesting as non-systemic polyarthritis, sacroiliitis or enthesitis.1,2 Key Updates The new recommendations appear in both Arthritis & Rheumatology…

Filed under:Clinical Criteria/Guidelines Tagged with:Enthesitisjuvenile idiopathic arthritis (JIA)polyarthritissacroiliitisSarah Ringold

New Guideline Recommends Frequent Monitoring & Collaboration for JIA-Associated Uveitis Management

Kelly Tyrrell  |  May 8, 2019

As soon as pediatric patients are diagnosed with juvenile idiopathic arthritis (JIA), they should also be screened for uveitis, says ophthalmologist Gary Holland, MD. Otherwise, the University of California, Los Angeles, provider says, “Kids who are diagnosed with JIA may not come to an ophthalmologist until they have vision-limiting complications.” Uveitis is the most common…

Filed under:Clinical Criteria/GuidelinesConditionsOther Rheumatic Conditions Tagged with:JIA-associated uveitis guidelinejuvenile idiopathic arthritis (JIA)Uveitis

Health Canada Approves Adalimumab for Chronic Non-Infectious Anterior Uveitis in Pediatric Patients

Michele B. Kaufman, PharmD, BCGP  |  April 3, 2019

Health Canada has approved adalimumab for treating chronic non-infectious anterior uveitis in patients 2 years and older…

Filed under:Biologics/DMARDsConditionsDrug UpdatesPediatric Conditions Tagged with:adalimumabnon-infectious anterior uveitisPediatricUveitis

Pediatric Uveitis in the Biologic Age: Risk Factors, Treatment & Outcomes

Lara C. Pullen, PhD  |  March 19, 2019

CHICAGO—The session on the topic of pediatric uveitis at the 2018 ACR/ARHP Annual Meeting began with a presentation by Debra A. Goldstein, MD, professor of ophthalmology and director of the Uveitis Service at the Feinberg School of Medicine, Northwestern University, Chicago. To a room packed with rheumatologists, she explained, “Most of what I am going…

Filed under:ConditionsMeeting Reports Tagged with:2018 ACR/ARHP Annual MeetingUveitis

2 Medical Schools Work to Improve Rheumatology Learning

Thomas R. Collins  |  February 18, 2019

CHICAGO—The pre-clinical rheumatology curriculum at the University of North Carolina (UNC) School of Medicine, Chapel Hill, used to consist mainly of portions of a musculoskeletal course, with up to only three instructional hours, and not always with a rheumatologist in the room with students. Systemic autoimmune diseases were never fully discussed in any of the…

Filed under:Education & TrainingMeeting ReportsProfessional Topics Tagged with:2018 ACR/ARHP Annual Meetingcurriculummedical school

  • « Previous Page
  • 1
  • …
  • 18
  • 19
  • 20
  • 21
  • 22
  • …
  • 37
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences